Steven R. Ph.d. Gullans

Director, Tetraphase Pharmaceuticals (United States).

Companies

iSpecimen Inc.Board member Jun 17, 2021 to now¹
MetaVia Inc.Board member Aug 4, 2016 to Jan 15, 2020²
MetaVia Inc.Chief executive officer May 31, 2017 to Jul 26, 2019³
MetaVia Inc.President May 31, 2017 to Jul 26, 2019³
Tetraphase Pharmaceuticals (United States)Board member Mar 19, 2013 to Jun 16, 2014⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

iSpecimen Inc. ISPC3,250 shares⁵$3.0K at $0.94Jan 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 1, 2023Granted 125 shares of iSpecimen Inc.⁵
Oct 1, 2022Granted 625 shares of iSpecimen Inc.⁶
Jul 30, 2021Granted 2,500 shares of iSpecimen Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARiSpecimen Inc., Board member
2
SEC EDGARMetaVia Inc., Board member
3
SEC EDGARMetaVia Inc., Chief executive officer
4
SEC EDGARTetraphase Pharmaceuticals (United States), Board member
5
SEC EDGARiSpecimen Inc. shares after the filing of Jan 1, 2023
6
SEC EDGARForm 5 filed Feb 10, 2023
7
SEC EDGARForm 5 filed Feb 14, 2022